HARP

Harpoon Therapeutics, Inc. Common Stock

Delisted

HARP was delisted on the 8th of March, 2024.

50 hedge funds and large institutions have $279M invested in Harpoon Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$12.9M
2 +$2.05M
3 +$1.28M
4
Millennium Management
Millennium Management
New York
+$1.23M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$710K

Top Sellers

1 -$8.42M
2 -$3.61M
3 -$2.02M
4
Goldman Sachs
Goldman Sachs
New York
-$158K
5
Northern Trust
Northern Trust
Illinois
-$79.6K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$303K
27
$297K
28
$233K
29
$199K
30
$189K
31
$180K
32
$164K
33
$163K
34
$160K
35
$117K
36
$73K
37
$68K
38
$57K
39
$51K
40
$35K
41
$26K
42
$21.6K
43
$21K
44
$14K
45
$9K
46
$8K
47
$5K
48
$4K
49
$3K
50
$2K